Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Medicaid Inflation Rebates Would Apply To More Products Under Line Extension Proposal

Executive Summary

Proposed rule also addresses impact of copay ‘accumulator’ programs on reporting Medicaid best prices and lays out more stringent requirements for manufacturers to be able to exclude such assistance from calculations.

You may also be interested in...

New Combo Products Exempt From Medicaid Rule Applying Price Inflation Rebates To Line Extensions

CMS final rule narrows definition of new formulations potentially subject to much higher Medicaid rebates and delays effective date of provisions targeting health plan copay accumulator programs.

Medicaid’s Multiple Best Price Proposal Needs More Clarity Before Advancing, PhRMA Argues

Medicaid should go back to the drawing board on a key part of its proposal aimed at circumventing best price reporting obstacles to value-based purchasing.

What Is A ‘Line Extension’? Medicaid Tries Again With Sweeping Definition

In the latest reminder of how badly industry lost the argument over the value of incremental improvements in formulations, US is proposing enhanced Medicaid rebates on virtually all new formulations of existing brands.

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts